Hepatobiliary Surgery Practice Questions

Q: Treatment of choice for mucinous carcinoma of the gall bladder in the early stage is -

Simple cholecystectomy. ***Simple cholecystectomy*** - For **early-stage (T1a) mucinous carcinoma of the gallbladder**, **simple cholecystectomy** is the treatment of choice - T1a disease (tumor confined to mucosa) has an excellent prognosis with **5-year survival >90%** after simple cholecystectomy alone - Extended resection offers **no survival benefit** for T1a disease and increases surgical morbidity - If incidentally discovered post-cholecystectomy with negative margins, no further surgery is needed *Extended cholecystectomy* - **Extended cholecystectomy** (cholecystectomy + liver segments IVb/V resection + portal lymphadenectomy) is indicated for **T2 or higher stage** disease (tumor invading muscularis propria or beyond) - This is **not** the treatment for early-stage disease as it increases morbidity without survival benefit - Reserved for more advanced tumors with deeper invasion *Cholecystectomy with wedge resection of liver* - This describes a component of extended cholecystectomy and is similarly indicated for **T2+ disease**, not early-stage - Wedge resection aims to achieve negative margins when tumor extends beyond the gallbladder wall - Not appropriate for early-stage mucinous carcinoma confined to mucosa *Chemotherapy only* - **Chemotherapy alone** is not curative for early-stage gallbladder carcinoma - Surgery remains the primary curative treatment for resectable disease - Chemotherapy is reserved for advanced, metastatic, or unresectable disease as palliative treatment

Q: In which of the following conditions is ERCP not indicated?

Proximal cholangiocarcinoma. ***Proximal cholangiocarcinoma*** - For **proximal/hilar cholangiocarcinoma** (Klatskin tumors at the **hepatic hilum**), **PTBD (Percutaneous Transhepatic Biliary Drainage)** is generally preferred over ERCP for biliary drainage. - The **high location** of these tumors makes endoscopic access difficult, with lower success rates and higher risk of complications like **cholangitis** and incomplete drainage. - **ERCP may fail** to adequately drain both hepatic ducts in bifurcation tumors, making PTBD the more reliable first-line approach. *Hepatic porta tumor* - **Hepatic porta tumors** involving the bile ducts are anatomically similar to **proximal cholangiocarcinoma**. - While ERCP can occasionally be attempted for porta hepatis lesions, **PTBD is often preferred** for high biliary obstructions due to better access to intrahepatic ducts. - The distinction is subtle, but **proximal cholangiocarcinoma** specifically refers to Klatskin tumors where ERCP has the **highest failure rate** and PTBD is most strongly preferred. *Distal CBD tumor* - **ERCP is the preferred modality** for **distal CBD tumors** to provide **biliary drainage**, tissue sampling (biopsy), and stent placement to relieve obstruction. - Direct endoscopic access to the distal common bile duct makes ERCP highly effective for diagnosis and palliation in this region. *Gallstone pancreatitis* - **ERCP is indicated** in **gallstone pancreatitis** when there is evidence of **cholangitis** or persistent **biliary obstruction** (e.g., rising liver enzymes, imaging showing retained stone in the CBD). - It allows for **therapeutic removal of impacted stones** from the common bile duct, preventing further pancreatic inflammation and complications.

Q: All of the following are causes of hemobilia, EXCEPT:

Hepatitis. ***Hepatitis*** - **Hepatitis** is an inflammation of the liver, typically caused by viral infections, alcohol, or autoimmune processes. While it can lead to liver damage and dysfunction, it does not typically cause **hemobilia**. - **Hemobilia** involves bleeding into the biliary tree, which is usually a result of vascular-biliary fistula formation; hepatitis primarily affects liver parenchymal cells and does not directly result in this type of bleeding. *Trauma to Abdomen* - **Abdominal trauma**, especially liver injuries, can lead to **vascular-biliary fistulae** or direct bleeding into the bile ducts, causing **hemobilia**. - Blunt or penetrating trauma can damage the liver parenchyma and blood vessels, allowing blood to enter the biliary system. *Malignancy* - **Malignant tumors** of the liver or biliary tract (e.g., **cholangiocarcinoma**, **hepatocellular carcinoma**) can erode into blood vessels and bile ducts, leading to **hemobilia**. - The growth of these tumors can rupture fragile vessels within the tumor or adjacent to it, causing blood to leak into the biliary tree. *Rupture of hepatic artery aneurysm* - A ruptured **hepatic artery aneurysm** is a significant and direct cause of **hemobilia**. - The forceful bleeding from the artery can breach the wall of an adjacent bile duct, creating a **fistula** and allowing arterial blood to enter the biliary system.

Q: In the Bismuth-Corlette classification, which type involves the hepatic duct confluence WITHOUT extension into secondary intrahepatic ducts?

Type II. ***Type II*** - This classification specifically describes **cholangiocarcinomas** located at the **hepatic duct confluence** without extension into secondary intrahepatic ducts. - **Type II tumors** involve the hepatic duct confluence but **do not extend** into the right or left secondary intrahepatic ducts. - This is the defining feature that distinguishes Type II from Type III variants. *Type I* - **Type I tumors** are located at least **2 cm distal to the hepatic duct bifurcation**. - This type involves the **common hepatic duct** and **spares the confluence** completely. - Does not meet the criteria of involving the confluence. *Type IIIa* - **Type IIIa tumors** involve the **hepatic duct confluence** with extension into the **right secondary intrahepatic ducts**. - This represents extension **beyond** the confluence, unlike Type II. - The extension into secondary ducts is the key differentiating feature. *Type IIIb* - **Type IIIb tumors** involve the **hepatic duct confluence** with extension into the **left secondary intrahepatic ducts**. - This represents extension **beyond** the confluence, unlike Type II. - The extension pattern differs from Type IIIa by involving the left rather than right system.

Q: In a patient with acute cholecystitis, referred pain to the shoulder is known as

Boas' sign. ***Boas' sign*** - **Boas' sign** refers to the presence of hyperesthesia below the right scapula, which can also manifest as referred pain to the **right shoulder** or back [1]. - This symptom in acute cholecystitis is due to the **irritation** of the **phrenic nerve**, which shares sensory pathways with the shoulder region. *Murphy's sign* - **Murphy's sign** is elicited by asking the patient to exhale, then placing the examiner's hand below the costal margin on the right mid-clavicular line, and then asking the patient to inhale deeply [1]. - A positive sign is indicated by a sudden cessation of inspiration due to pain, which is specific for **acute cholecystitis** and not referred shoulder pain [1]. *Gray Turner sign* - The **Gray Turner sign** involves ecchymosis or discoloration of the flanks. - It is a severe indicator of **retroperitoneal hemorrhage**, often associated with acute pancreatitis, not cholecystitis [2]. *Cullen's sign* - **Cullen's sign** presents as periumbilical ecchymosis or discoloration around the navel. - This sign is also indicative of **retroperitoneal hemorrhage**, typically seen in serious conditions like ruptured ectopic pregnancy or acute pancreatitis.

Q: What is the standard intercostal space used for hepatic biopsy?

9th. ***Correct Option: 9th*** - The **9th intercostal space** in the mid-axillary line is the standard and most commonly used entry point for percutaneous liver biopsy. - This location provides safe access to the **right lobe of the liver** while avoiding injury to the **pleura** and **lungs** superiorly and minimizing risk to the **kidney** and other abdominal organs inferiorly. - At this level, the liver is sufficiently large and the approach avoids the pleural reflection, which typically descends to the 8th-9th intercostal space. - Standard surgical textbooks (Sabiston, Schwartz) recommend the **8th-10th intercostal space**, with the 9th being most frequently used. *Incorrect Option: 5th* - The **5th intercostal space** is far too high for liver biopsy and would result in puncturing the **lung** or **pleura**, causing **pneumothorax** or hemothorax. - This space is well above the liver margin and is not suitable for hepatic access. *Incorrect Option: 7th* - While the **7th intercostal space** may occasionally be mentioned, it is generally considered **too high** for routine percutaneous liver biopsy. - This level carries increased risk of **pleural injury** as the pleural reflection may extend to this level, especially during deep inspiration. - It is not the standard or preferred approach in current surgical practice. *Incorrect Option: 11th* - The **11th intercostal space** is too low and significantly increases the risk of injuring the **right kidney** or entering the peritoneal cavity with potential injury to bowel or other abdominal structures. - This space is below the optimal liver access zone and is not recommended for routine liver biopsy.

Q: All of the following are risk factors for carcinoma of the gallbladder, EXCEPT -

Oral contraceptives. ***Oral contraceptives*** - While **oral contraceptives** can increase the risk of **gallstones**, they are not directly recognized as a specific risk factor for **gallbladder carcinoma**. - The impact of oral contraceptives on gallbladder cancer risk is generally considered to be minor or non-existent compared to established risk factors. *Typhoid carriers* - **Chronic asymptomatic carriers of Salmonella Typhi** have a significantly increased risk of developing **gallbladder carcinoma**, likely due to chronic inflammation and cellular damage. - The bacteria can reside in the gallbladder for years, leading to a persistent inflammatory state and genetic mutations. *Adenomatous gall bladder polyps* - **Adenomatous polyps** in the gallbladder are considered **premalignant lesions**, especially if they are larger than 10 mm, and are associated with an increased risk of progression to adenocarcinoma. - Their presence indicates a need for careful monitoring and often surgical removal due to their malignant potential. *Choledochal cysts* - **Choledochal cysts**, congenital dilations of the bile ducts, are well-established risk factors for **cholangiocarcinoma** (bile duct cancer) and, less commonly, **gallbladder carcinoma**. - The stasis and reflux of bile within these cysts lead to chronic irritation and inflammation, increasing the risk of malignant transformation.

Q: Which of the following is not an indication for percutaneous aspiration, injection, and reaspiration treatment in hydatid cyst?

Size 5 cm) that are symptomatic or at risk of complications. - Smaller cysts (< 5 cm) may be managed with **medical therapy alone** (albendazole) or monitored, as the risks of PAIR might outweigh the benefits in small cysts. - This is **NOT an indication** for PAIR. *Unilocular cyst* - **Unilocular cysts** (WHO CE1 and CE3a types) are ideal candidates for PAIR because their simple structure allows for effective aspiration and scolicidal agent instillation. - **Multiseptated or multiloculated cysts** are contraindications for PAIR due to multiple compartments limiting scolicidal agent distribution. - This **IS an indication** for PAIR. *Cyst in lung* - **Pulmonary hydatid cysts are a contraindication to PAIR** due to high risk of complications including anaphylaxis, bronchial spillage, pneumothorax, and empyema. - Lung cysts are primarily treated with **surgery** (cystotomy, capitonnage, or lobectomy). - However, in the context of this question, some sources may consider PAIR for lung cysts in highly selected cases, making "size < 5 cm" the more definitive non-indication. *Cyst in liver* - The **liver** is the most common site for hydatid cysts (50-70% of cases), and PAIR is a well-established and effective treatment option for hepatic hydatidosis. - PAIR is considered a safe, minimally invasive alternative to surgery for appropriately selected liver cysts. - This **IS an indication** for PAIR.

Q: Referred pain to the inferior angle of the right scapula in acute cholecystitis is known as

Boa's sign. ***Boa's sign*** - This sign is characterized by **referred pain** to the **inferior angle of the right scapula** due to irritation of the **phrenic nerve** (C3-C5 dermatomes) by an inflamed gallbladder [1]. - The pain is typically felt unilaterally on the right side and is a classic presentation in **acute cholecystitis** [1]. *Murphy's sign* - This is a test for acute cholecystitis, characterized by **inspiratory arrest** upon deep palpation of the right upper quadrant under the costal margin [1]. - It indicates **visceral tenderness** of the gallbladder itself, rather than referred pain to the scapula. *Naunyn's sign* - This sign is not a recognized clinical sign associated with acute cholecystitis or referred pain patterns in common medical practice. - There might be confusion with other eponymous signs that are not directly related to gallbladder pathology and referred scapular pain. *Cullen's sign* - This sign refers to **periumbilical ecchymosis** (bruising around the umbilicus). - It is indicative of **retroperitoneal hemorrhage**, such as in acute pancreatitis [2] or ruptured ectopic pregnancy, not acute cholecystitis.

Q: Pringle's manoeuvre may be required for treatment of

Liver laceration. ***Liver laceration*** - **Pringle's manoeuvre** involves clamping the **hepatoduodenal ligament** to control blood flow to the liver, effectively managing bleeding from **liver lacerations**. - This maneuver helps to differentiate between hepatic and non-hepatic bleeding sources during abdominal surgery. *Injury to tail of pancreas* - An injury to the **tail of the pancreas** is usually managed by surgical resection or repair of the damaged pancreatic tissue, and Pringle's manoeuvre does not directly address this. - The pancreas is supplied by branches of the **celiac axis** and **superior mesenteric artery**, which are not occluded by Pringle's manoeuvre. *Mesenteric ischemia* - **Mesenteric ischemia** is a condition involving reduced blood flow to the intestines via the **mesenteric arteries**; Pringle's manoeuvre would not be an appropriate treatment. - Treatment for mesenteric ischemia typically involves revascularization of the affected mesenteric vessels. *Bleeding esophageal varices* - **Bleeding esophageal varices** are managed by therapies like **endoscopic band ligation**, sclerotherapy, or octreotide infusion. - Pringle's manoeuvre is not indicated for treating bleeding from esophageal varices, as these are related to portal hypertension and not direct hepatic artery/portal vein bleeds.

Question 1

Treatment of choice for mucinous carcinoma of the gall bladder in the early stage is -

Accepted Answer

Simple cholecystectomy

Answer

Extended cholecystectomy

Answer

Cholecystectomy with wedge resection of liver

Answer

Chemotherapy only

Question 2

In which of the following conditions is ERCP not indicated?

Accepted Answer

Proximal cholangiocarcinoma

Answer

Distal CBD tumor

Answer

Hepatic porta tumor

Answer

Gall stone pancreatitis

Question 3

All of the following are causes of hemobilia, EXCEPT:

Accepted Answer

Hepatitis

Answer

Trauma to Abdomen

Answer

Rupture of hepatic artery aneurysm

Answer

Malignancy

Question 4

In the Bismuth-Corlette classification, which type involves the hepatic duct confluence WITHOUT extension into secondary intrahepatic ducts?

Accepted Answer

Type II

Answer

Type IIIb

Answer

Type I

Answer

Type IV

Answer

Type IIIa

Answer

Type III

Question 5

In a patient with acute cholecystitis, referred pain to the shoulder is known as

Accepted Answer

Boas' sign

Answer

Murphy's sign

Answer

Gray Turner sign

Answer

Cullen's sign

Question 6

What is the standard intercostal space used for hepatic biopsy?

Accepted Answer

9th

Answer

5th

Answer

7th

Answer

11th

Question 7

All of the following are risk factors for carcinoma of the gallbladder, EXCEPT -

Accepted Answer

Oral contraceptives

Answer

Adenomatous gall bladder polyps

Answer

Choledochal cysts

Answer

Typhoid carriers

Question 8

Which of the following is not an indication for percutaneous aspiration, injection, and reaspiration treatment in hydatid cyst?

Accepted Answer

Size < 5 cm

Answer

Unilocular cyst

Answer

Cyst in lung

Answer

Cyst in liver

Question 9

Referred pain to the inferior angle of the right scapula in acute cholecystitis is known as

Accepted Answer

Boa's sign

Answer

Murphy's sign

Answer

Naunyn's sign

Answer

Cullen's sign

Question 10

Pringle's manoeuvre may be required for treatment of

Accepted Answer

Liver laceration

Answer

Injury to tail of pancreas

Answer

Bleeding esophageal varices

Answer

Mesenteric ischemia

Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?